Bertero, Edoardo https://orcid.org/0000-0002-3175-8151
Heusch, Gerd https://orcid.org/0000-0001-7078-4160
Münzel, Thomas https://orcid.org/0000-0001-5503-4150
Maack, Christoph https://orcid.org/0000-0003-3694-4559
Article History
Accepted: 24 May 2021
First Online: 7 July 2021
Competing interests
: C.M. has received honoraria as a lecturer from AstraZeneca, Bayer, Berlin Chemie, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis and Servier and has served as an adviser to Amgen, Boehringer Ingelheim, Novo Nordisk and Servier. The other authors declare no competing interests.